Tallon Kerry Patrick acquired a new stake in shares of Quanterix Co. (NASDAQ:QTRX – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund acquired 15,710 shares of the company’s stock, valued at approximately $169,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. nVerses Capital LLC bought a new stake in shares of Quanterix during the 3rd quarter valued at $60,000. Peapack Gladstone Financial Corp bought a new stake in shares of Quanterix during the 3rd quarter valued at $131,000. Canada Pension Plan Investment Board bought a new stake in shares of Quanterix during the 2nd quarter valued at $140,000. SG Americas Securities LLC bought a new stake in shares of Quanterix during the 3rd quarter valued at $139,000. Finally, Hsbc Holdings PLC raised its stake in shares of Quanterix by 34.7% during the 2nd quarter. Hsbc Holdings PLC now owns 12,738 shares of the company’s stock valued at $164,000 after purchasing an additional 3,279 shares during the period. 86.48% of the stock is currently owned by institutional investors.
Quanterix Stock Performance
Quanterix stock opened at $8.82 on Friday. Quanterix Co. has a 52 week low of $8.21 and a 52 week high of $29.70. The business has a 50-day simple moving average of $11.43 and a 200 day simple moving average of $12.55.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on Quanterix
Quanterix Company Profile
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Read More
- Five stocks we like better than Quanterix
- Upcoming IPO Stock Lockup Period, Explained
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Stock Market Upgrades: What Are They?
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Why Are These Companies Considered Blue Chips?
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.